Shionogi & Co., Ltd. (OTCMKTS:SGIOF) Short Interest Update

Shionogi & Co., Ltd. (OTCMKTS:SGIOF) was the recipient of a large growth in short interest in the month of January. As of January 15th, there was short interest totalling 2,587,700 shares, a growth of 36.3% from the December 31st total of 1,898,000 shares. Based on an average daily volume of 100 shares, the days-to-cover ratio is currently 25,877.0 days.

Shionogi & Co., Ltd. Stock Performance

OTCMKTS:SGIOF remained flat at $14.19 during trading on Friday. The business’s fifty day moving average is $12.97 and its two-hundred day moving average is $24.52. Shionogi & Co., Ltd. has a 1-year low of $12.21 and a 1-year high of $17.83.

About Shionogi & Co., Ltd.

Shionogi & Co, Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Cabenuva and Apretude an anti-HIV and HIV prophylactic drug; Xocova an oral COVID-19 treatment drug; Finibax a carbapenem antibiotic; Xofluza, an influenza antiviral drug; and Tivicay, an anti-HIV drug.